KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) EPS (Weighted Average and Diluted): 2009-2024

Historic EPS (Weighted Average and Diluted) for Acadia Pharmaceuticals (ACAD) over the last 9 years, with Dec 2024 value amounting to $1.36.

  • Acadia Pharmaceuticals' EPS (Weighted Average and Diluted) rose 110.00% to $0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.55, marking a year-over-year increase of 98.72%. This contributed to the annual value of $1.36 for FY2024, which is 467.57% up from last year.
  • According to the latest figures from FY2024, Acadia Pharmaceuticals' EPS (Weighted Average and Diluted) is $1.36, which was up 467.57% from -$0.37 recorded in FY2023.
  • Over the past 5 years, Acadia Pharmaceuticals' EPS (Weighted Average and Diluted) peaked at $1.36 during FY2024, and registered a low of -$1.79 during FY2020.
  • For the 3-year period, Acadia Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$0.12, with its median value being -$0.37 (2023).
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first declined by 27.62% in 2022, then skyrocketed by 467.57% in 2024.
  • Over the past 5 years, Acadia Pharmaceuticals' EPS (Weighted Average and Diluted) (Yearly) stood at -$1.79 in 2020, then spiked by 41.34% to -$1.05 in 2021, then declined by 27.62% to -$1.34 in 2022, then soared by 72.39% to -$0.37 in 2023, then spiked by 467.57% to $1.36 in 2024.